Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04684602 · ClinicalTrials.gov registry record · Phase 1
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
A Phase 1 study of Autoimmune Diseases and Sexual Dysfunction, sponsored by Thomas Advanced Medical.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT04684602 is a Phase 1 study of Autoimmune Diseases and Sexual Dysfunction that is actively recruiting participants, run by Thomas Advanced Medical. The registered enrollment target is 5,000 participants, above the 778-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (543% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04684602, a Phase 1 study of Autoimmune Diseases and Sexual Dysfunction, is actively recruiting participants, sponsored by Thomas Advanced Medical.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Conditions Studied
Interventions
- BIOLOGICAL PrimePro™/ PrimeMSK™
Study Locations (1)
California
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites - Culver City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2020-07-09 |
| Est. Completion | 2030-12-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04684602
The ClinicalTrials.gov registry entry for NCT04684602 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 778-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (543% higher). The listed sponsor is Thomas Advanced Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Autoimmune Diseases appearing as the primary indexed condition, and to 1 intervention - of which PrimePro™/ PrimeMSK™ is the first listed.
NCT04684602 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04684602 about?
NCT04684602 is a clinical study titled "Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions". This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for...
What is the current status of trial NCT04684602?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 5,000 participants. The study started on 2020-07-09. Estimated completion is 2030-12-09.
What conditions does trial NCT04684602 study?
This clinical trial studies the following conditions: Autoimmune Diseases, Sexual Dysfunction, Diabetes Complications, Neurologic Disorders, Cardiovascular Disorders.
What interventions are being tested in trial NCT04684602?
The interventions under investigation include: PrimePro™/ PrimeMSK™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT04684602?
This trial is sponsored by Thomas Advanced Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04684602 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autoimmune Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RECRUITING · Phase 1
-
A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects
COMPLETED · Phase 1
-
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
COMPLETED · Phase 1
-
Rheumatology Diet Study
RECRUITING
-
Collection and Distribution of Biospecimens for Novel Research Uses
RECRUITING
-
Ovarian Tissue Cryopreservation for Fertility Preservation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.